Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD, 21205, USA.
Brown University, 121 S. Main St, Providence, RI, 02903, USA.
Environ Res. 2022 Sep;212(Pt B):113320. doi: 10.1016/j.envres.2022.113320. Epub 2022 Apr 22.
Early life phthalate exposures may disrupt metabolism but results from human studies are inconsistent and few have examined body composition during adolescence. We investigated associations of gestational and childhood urinary phthalate biomarker concentrations with body composition at age 12 years.
We used data from 206 mother-child pairs in a prospective pregnancy and birth cohort enrolled in Cincinnati, OH from 2003 to 2006. We measured nine phthalate metabolites in spot urine samples collected twice from mothers during pregnancy and up to seven times from children at 1, 2, 3, 4, 5, 8, and 12 years. At age 12 years, we assessed fat and lean mass of the whole body and android and gynoid subregions, and visceral fat area with dual x-ray absorptiometry, and calculated android to gynoid %fat ratio and age- and sex-standardized fat and lean mass index z-scores. Using a multiple informant model, we estimated covariate-adjusted associations between urinary phthalate biomarker concentrations at each time period and outcomes at age 12 years. We assessed effect measure modification by child sex using stratified models.
Generally, urinary mono-benzyl phthalate (MBzP) concentrations were modestly associated with lower fat and lean mass. Each 10-fold increase in urinary MBzP concentrations during gestation and at ages 5 and 8 years was associated with a -0.34 (95%CI: -0.72, 0.05), -0.44 (95% CI: -0.83, -0.05), and -0.35 (95% CI: -0.71, 0.00) z-score difference in lean body mass index, respectively. Urinary monoethyl phthalate, mono-(3-carboxypropyl) phthalate, and summed di(2-ethylhexyl) phthalate metabolites were associated with greater lean mass at some exposure periods. Slightly weaker but similar patterns of association were found with other body composition measures; associations did not differ by child sex.
While most associations were weak, exposure to certain phthalates during gestation and childhood may be associated with adolescent body composition, particularly lean mass.
早期生活中邻苯二甲酸酯的暴露可能会破坏新陈代谢,但来自人类研究的结果并不一致,而且很少有研究在青春期检查身体成分。我们调查了妊娠和儿童时期尿液中邻苯二甲酸酯生物标志物浓度与 12 岁时身体成分的关系。
我们使用了 206 对母子在俄亥俄州辛辛那提进行的前瞻性妊娠和出生队列研究的数据,该研究于 2003 年至 2006 年进行。我们测量了母亲在妊娠期间两次和儿童在 1、2、3、4、5、8 和 12 岁时最多七次的两次尿液样本中的 9 种邻苯二甲酸酯代谢物。在 12 岁时,我们使用双能 X 线吸收法评估了全身和安卓和女性部位的脂肪和瘦体重,以及内脏脂肪面积,并计算了安卓到女性部位的%脂肪比和年龄和性别标准化的脂肪和瘦体重指数 z 分数。使用多信息模型,我们根据每个时间段的尿液邻苯二甲酸酯生物标志物浓度,估计了与 12 岁时的结果之间的协变量调整关联。我们使用分层模型评估了儿童性别对效应量修正的影响。
一般来说,单苄基邻苯二甲酸酯(MBzP)的尿液浓度与较低的脂肪和瘦体重呈中度相关。妊娠期间和 5 岁和 8 岁时尿液中 MBzP 浓度每增加 10 倍,瘦体重指数的 z 分数差异分别为-0.34(95%CI:-0.72,0.05)、-0.44(95%CI:-0.83,-0.05)和-0.35(95%CI:-0.71,0.00)。尿液中单乙基邻苯二甲酸酯、单-(3-羧基丙基)邻苯二甲酸酯和二-(2-乙基己基)邻苯二甲酸酯代谢物与某些暴露期的瘦体重增加有关。与其他身体成分测量值也存在稍弱但类似的关联模式;关联在儿童性别之间没有差异。
虽然大多数关联较弱,但妊娠和儿童时期接触某些邻苯二甲酸酯可能与青少年身体成分有关,尤其是瘦体重。